Bibliometric Analysis of Studies Employing Nanotechnology for MRSA Treatment, 2007-2025

Antibiotic resistance in bacteria remains a pressing concern highlighted by the World Health Organization. In response, alongside efforts to discover new antibiotics, researchers have increasingly turned to nanotechnology to develop antibacterial agents targeting antibiotic-resistant strains or to enhance the effectiveness of existing treatments, such as through the use of nanocarriers. Methicillin-resistant Staphylococcus aureus (MRSA) is one such bacterium that has garnered extensive attention due to the difficulties associated with its treatment. In this overview, we examine research studies from 2007 to 2025 focused on MRSA treatment utilizing nanotechnology. For this analysis, we tapped into the Scopus database as one of the primary sources for bibliometric surveys to collect relevant data and employed VOSviewer software for data visualization and networking purposes. Our findings reveal that China is the leading contributor of research papers in this arena, with Chinese institutions ranking at the forefront as well. Notably, among the top 10 countries producing research in this field, 70% are from Asia. The publication trend has shown a staggering increase of approximately 9,000% from 2007 to 2024. Additionally, nanozymes have emerged as a particularly exciting research topic, drawing significant interest over recent years due to their high potential. Given the capabilities of nanoscience and its ongoing advancements, a promising future is anticipated for this area of research.